Cargando…
Peroxiredoxins in Neurodegenerative Diseases
Substantial evidence indicates that oxidative/nitrosative stress contributes to the neurodegenerative diseases. Peroxiredoxins (PRDXs) are one of the enzymatic antioxidant mechanisms neutralizing reactive oxygen/nitrogen species. Since mammalian PRDXs were identified 30 years ago, their significance...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761365/ https://www.ncbi.nlm.nih.gov/pubmed/33265993 http://dx.doi.org/10.3390/antiox9121203 |
_version_ | 1783627551710642176 |
---|---|
author | Szeliga, Monika |
author_facet | Szeliga, Monika |
author_sort | Szeliga, Monika |
collection | PubMed |
description | Substantial evidence indicates that oxidative/nitrosative stress contributes to the neurodegenerative diseases. Peroxiredoxins (PRDXs) are one of the enzymatic antioxidant mechanisms neutralizing reactive oxygen/nitrogen species. Since mammalian PRDXs were identified 30 years ago, their significance was long overshadowed by the other well-studied ROS/RNS defense systems. An increasing number of studies suggests that these enzymes may be involved in the neurodegenerative process. This article reviews the current knowledge on the expression and putative roles of PRDXs in neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease and dementia with Lewy bodies, multiple sclerosis, amyotrophic lateral sclerosis and Huntington’s disease. |
format | Online Article Text |
id | pubmed-7761365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77613652020-12-26 Peroxiredoxins in Neurodegenerative Diseases Szeliga, Monika Antioxidants (Basel) Review Substantial evidence indicates that oxidative/nitrosative stress contributes to the neurodegenerative diseases. Peroxiredoxins (PRDXs) are one of the enzymatic antioxidant mechanisms neutralizing reactive oxygen/nitrogen species. Since mammalian PRDXs were identified 30 years ago, their significance was long overshadowed by the other well-studied ROS/RNS defense systems. An increasing number of studies suggests that these enzymes may be involved in the neurodegenerative process. This article reviews the current knowledge on the expression and putative roles of PRDXs in neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease and dementia with Lewy bodies, multiple sclerosis, amyotrophic lateral sclerosis and Huntington’s disease. MDPI 2020-11-30 /pmc/articles/PMC7761365/ /pubmed/33265993 http://dx.doi.org/10.3390/antiox9121203 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Szeliga, Monika Peroxiredoxins in Neurodegenerative Diseases |
title | Peroxiredoxins in Neurodegenerative Diseases |
title_full | Peroxiredoxins in Neurodegenerative Diseases |
title_fullStr | Peroxiredoxins in Neurodegenerative Diseases |
title_full_unstemmed | Peroxiredoxins in Neurodegenerative Diseases |
title_short | Peroxiredoxins in Neurodegenerative Diseases |
title_sort | peroxiredoxins in neurodegenerative diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761365/ https://www.ncbi.nlm.nih.gov/pubmed/33265993 http://dx.doi.org/10.3390/antiox9121203 |
work_keys_str_mv | AT szeligamonika peroxiredoxinsinneurodegenerativediseases |